Key role for ubiquitin protein modification in TGFβ signal transduction

References

• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature. 2003;425:577–84.
   PubMed Web of Science ®Google Scholar
• Mu Y, Gudey SK, Landstrom M. Non-Smad signaling pathways. Cell Tissue Res. 2012;347:11–20.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay B, Han A, Dai J, Fan J, Li Y, Chen M, TβRI/Alk5-independent TβRII signaling to ERK1/2 in human skin cells according to distinct levels of TβRII expression. J Cell Sci. 2011;124:19–24.
   PubMed Web of Science ®Google Scholar
• Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550–63.
   PubMed Web of Science ®Google Scholar
• Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425–79.
   PubMed Web of Science ®Google Scholar
• Behrends C, Harper JW. Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol. 2011;18:520–8.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell. 1997;89:1165–73.
   PubMed Web of Science ®Google Scholar
• Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Smad6 inhibits signalling by the TGF-β superfamily. Nature. 1997;389:622–6.
   PubMed Web of Science ®Google Scholar
• Wiesner S, Ogunjimi AA, Wang HR, Rotin D, Sicheri F, Wrana JL, Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell. 2007;130:651–62.
   PubMed Web of Science ®Google Scholar
• Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem. 2001;276:12477–80.
   PubMed Web of Science ®Google Scholar
• Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell. 2003;14:2809–17.
   PubMed Web of Science ®Google Scholar
• Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol Cell. 2000;6:1365–75.
   PubMed Web of Science ®Google Scholar
• Finnson KW, Tam BY, Liu K, Marcoux A, Lepage P, Roy S, Identification of CD109 as part of the TGF-β receptor system in human keratinocytes. FASEB J. 2006;20:1525–7.
   PubMed Web of Science ®Google Scholar
• Bizet AA, Tran-Khanh N, Saksena A, Liu K, Buschmann MD, Philip A. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. J Cell Biochem. 2012;113:238–46.
   PubMed Web of Science ®Google Scholar
• Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene. 2004;23:6914–23.
   PubMed Web of Science ®Google Scholar
• Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J. 2005;386:461–70.
   PubMed Web of Science ®Google Scholar
• Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 1999;400:687–93.
   PubMed Web of Science ®Google Scholar
• Lin X, Liang M, Feng XH. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J Biol Chem. 2000;275:36818–22.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A. 2001;98:974–9.
   PubMed Web of Science ®Google Scholar
• Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, CHIP controls the sensitivity of transforming growth factor-β signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem. 2005;280:20842–50.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu YT, Hao R, Chen L, Chang Z, Wang HR, Molecular mechanism of the negative regulation of Smad1/5 protein by carboxyl terminus of Hsc70-interacting protein (CHIP). J Biol Chem. 2011;286:15883–94.
   PubMed Web of Science ®Google Scholar
• Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling. Genes Dev. 2008;22:106–20.
   PubMed Web of Science ®Google Scholar
• Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell. 2007;131:980–93.
   PubMed Web of Science ®Google Scholar
• Nakano A, Koinuma D, Miyazawa K, Uchida T, Saitoh M, Kawabata M, Pin1 down-regulates transforming growth factor-β (TGF-β) signaling by inducing degradation of Smad proteins. J Biol Chem. 2009;284:6109–15.
   PubMed Web of Science ®Google Scholar
• Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell. 2009;36:457–68.
   PubMed Web of Science ®Google Scholar
• Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell. 2001;12:1431–43.
   PubMed Web of Science ®Google Scholar
• Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell. 2009;139:757–69.
   PubMed Web of Science ®Google Scholar
• Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massague J, A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev. 2011;25:1275–88.
   PubMed Web of Science ®Google Scholar
• Mavrakis KJ, Andrew RL, Lee KL, Petropoulou C, Dixon JE, Navaratnam N, Arkadia enhances Nodal/TGF-β signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol. 2007;5:67.
   PubMed Web of Science ®Google Scholar
• Moren A, Imamura T, Miyazono K, Heldin CH, Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem. 2005;280:22115–23.
   PubMed Web of Science ®Google Scholar
• Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X, Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep. 2002;3:171–6.
   PubMed Web of Science ®Google Scholar
• Li L, Xin H, Xu X, Huang M, Zhang X, Chen Y, CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol. 2004;24:856–64.
   PubMed Web of Science ®Google Scholar
• Wan M, Tang Y, Tytler EM, Lu C, Jin B, Vickers SM, Smad4 protein stability is regulated by ubiquitin ligase SCF β-TrCP1. J Biol Chem. 2004;279:14484–7.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang N, Tang Y, Cao X, Wan M. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation. Hum Mutat. 2006;27:897–905.
   PubMed Web of Science ®Google Scholar
• Wan M, Huang J, Jhala NC, Tytler EM, Yang L, Vickers SM, SCF(β-TrCP1) controls Smad4 protein stability in pancreatic cancer cells. Am J Pathol. 2005;166:1379–92.
   PubMed Web of Science ®Google Scholar
• Ito I, Hanyu A, Wayama M, Goto N, Katsuno Y, Kawasaki S, Estrogen inhibits transforming growth factor β signaling by promoting Smad2/3 degradation. J Biol Chem. 2010;285:14747–55.
   PubMed Web of Science ®Google Scholar
• Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, Hanyu A, Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J. 2003;22:6458–70.
   PubMed Web of Science ®Google Scholar
• Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling. J Biol Chem. 2007;282:20492–501.
   PubMed Web of Science ®Google Scholar
• Wu JW, Krawitz AR, Chai J, Li W, Zhang F, Luo K, Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling. Cell. 2002;111:357–67.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K. C-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene. 2004;23:5068–76.
   PubMed Web of Science ®Google Scholar
• Tabata T, Kokura K, Ten Dijke P, Ishii S. Ski co-repressor complexes maintain the basal repressed state of the TGF-β target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells. 2009;14:17–28.
   PubMed Web of Science ®Google Scholar
• Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K, TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol. 2001;3:587–95.
   PubMed Web of Science ®Google Scholar
• Stroschein SL, Bonni S, Wrana JL, Luo K. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev. 2001;15:2822–36.
   PubMed Web of Science ®Google Scholar
• Koinuma D, Shinozaki M, Nagano Y, Ikushima H, Horiguchi K, Goto K, RB1CC1 positively regulates transforming growth factor-{β} signaling through the modulation of Arkadia E3 ubiquitin ligase activity. J Biol Chem. 2011;286:32502–12.
   PubMed Web of Science ®Google Scholar
• Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 2006;25:1646–58.
   PubMed Web of Science ®Google Scholar
• Bengoechea-Alonso MT, Ericsson J. Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation. Oncogene. 2010;29:5322–8.
   PubMed Web of Science ®Google Scholar
• Soond SM, Chantry A. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT. Oncogene. 2011;30:2451–62.
   PubMed Web of Science ®Google Scholar
• Hu D, Wan Y. Regulation of Kruppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-β signaling. J Biol Chem. 2011;286:6890–901.
   PubMed Web of Science ®Google Scholar
• Andrews PS, Schneider S, Yang E, Michaels M, Chen H, Tang J, Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays. Assay Drug Dev Technol. 2010;8:471–87.
   Google Scholar
• Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science. 2005;307:1603–9.
   PubMed Web of Science ®Google Scholar
• Cheng PL, Lu H, Shelly M, Gao H, Poo MM. Phosphorylation of E3 ligase Smurf1 switches its substrate preference in support of axon development. Neuron. 2011;69:231–43.
   PubMedGoogle Scholar
• Tian M, Bai C, Lin Q, Lin H, Liu M, Ding F, Binding of RhoA by the C2 domain of E3 ligase Smurf1 is essential for Smurf1-regulated RhoA ubiquitination and cell protrusive activity. FEBS Lett. 2011;585:2199–204.
   PubMed Web of Science ®Google Scholar
• Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P, Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell. 2009;137:295–307.
   PubMed Web of Science ®Google Scholar
• Lee YS, Park JS, Kim JH, Jung SM, Lee JY, Kim SJ, Smad6-specific recruitment of Smurf E3 ligases mediates TGF-β1-induced degradation of MyD88 in TLR4 signalling. Nat Commun. 2011;2:460.
   PubMed Web of Science ®Google Scholar
• Kalkan T, Iwasaki Y, Park CY, Thomsen GH. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-β signaling that affects neural crest formation. Mol Biol Cell. 2009;20:3436–50.
   PubMed Web of Science ®Google Scholar
• Li S, Lu K, Wang J, An L, Yang G, Chen H, Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Mol Cell Biochem. 2010;338:11–17.
   PubMedGoogle Scholar
• Carpentier I, Coornaert B, Beyaert R. Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activation. Biochem Biophys Res Commun. 2008;374:752–7.
   PubMed Web of Science ®Google Scholar
• Lu K, Li P, Zhang M, Xing G, Li X, Zhou W, Pivotal role of the C2 domain of the Smurf1 ubiquitin ligase in substrate selection. J Biol Chem. 2011;286:16861–70.
   PubMed Web of Science ®Google Scholar
• Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene. 2005;24:8080–4.
   PubMed Web of Science ®Google Scholar
• Cutts AJ, Soond SM, Powell S, Chantry A. Early phase TGFβ receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses. Int J Biochem Cell Biol. 2011;43:604–12.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Thornton AM, Kinney MC, Ma CA, Spinner JJ, Fuss IJ, The deubiquitinase CYLD targets Smad7 to regulate TGF-{β} signaling and the development of regulatory T cells. J Biol Chem. 2011;286:40520–30.
   PubMed Web of Science ®Google Scholar
• Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol. 2011;13:1368–75.
   Google Scholar
• Tanaka N, Kaneko K, Asao H, Kasai H, Endo Y, Fujita T, Possible involvement of a novel STAM-associated molecule "AMSH" in intracellular signal transduction mediated by cytokines. J Biol Chem. 1999;274:19129–35.
   PubMed Web of Science ®Google Scholar
• Itoh F, Asao H, Sugamura K, Heldin CH, Ten Dijke P, Itoh S. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 2001;20:4132–42.
   PubMed Web of Science ®Google Scholar
• Ibarrola N, Kratchmarova I, Nakajima D, Schiemann WP, Moustakas A, Pandey A, Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor β signaling. BMC Cell Biol. 2004;5:2.
   PubMedGoogle Scholar
• Li H, Seth A. An RNF11: Smurf2 complex mediates ubiquitination of the AMSH protein. Oncogene. 2004;23:1801–8.
   PubMed Web of Science ®Google Scholar
• Sato Y, Yoshikawa A, Yamagata A, Mimura H, Yamashita M, Ookata K, Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature. 2008;455:358–62.
   PubMed Web of Science ®Google Scholar
• Clague MJ, Urbe S. Endocytosis: the DUB version. Trends Cell Biol. 2006;16:551–9.
   Google Scholar
• Bai Y, Yang C, Hu K, Elly C, Liu YC. Itch E3 ligase-mediated regulation of TGF-β signaling by modulating smad2 phosphorylation. Mol Cell. 2004;15:825–31.
   PubMed Web of Science ®Google Scholar
• Wohlfert EA, Gorelik L, Mittler R, Flavell RA, Clark RB. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-β sensitivity in vitro and in vivo. J Immunol. 2006;176:1316–20.
   PubMed Web of Science ®Google Scholar
• Adams CO, Housley WJ, Bhowmick S, Cone RE, Rajan TV, Forouhar F, Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-β. J Immunol. 2010;185:2051–8.
   PubMed Web of Science ®Google Scholar
• Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell. 2005;12:87–99.
   Google Scholar
• Agricola E, Randall RA, Gaarenstroom T, Dupont S, Hill CS. Recruitment of TIF1gamma to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell. 2011;43:85–96.
   PubMed Web of Science ®Google Scholar
• Wang B, Suzuki H, Kato M. Roles of mono-ubiquitinated Smad4 in the formation of Smad transcriptional complexes. Biochem Biophys Res Commun. 2008;376:288–92.
   PubMed Web of Science ®Google Scholar
• Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination. Cell. 2009;136:123–35.
   PubMed Web of Science ®Google Scholar
• Morsut L, Yan KP, Enzo E, Aragona M, Soligo SM, Wendling O, Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. Development. 2010;137:2571–8.
   PubMed Web of Science ®Google Scholar
• Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol. 2008;10:1199–207.
   PubMed Web of Science ®Google Scholar
• Fan YH, Yu Y, Mao RF, Tan XJ, Xu GF, Zhang H, USP4 targets TAK1 to downregulate TNFalpha-induced NF-kappaB activation. Cell Death Differ. 2011;18:1547–60.
   PubMed Web of Science ®Google Scholar
• Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymovych M, TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun. 2011;2:330.
   PubMed Web of Science ®Google Scholar
• Lee PS, Chang C, Liu D, Derynck R. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-β family signaling. J Biol Chem. 2003;278:27853–63.
   PubMed Web of Science ®Google Scholar
• Lin X, Liang M, Liang YY, Brunicardi FC, Melchior F, Feng XH. Activation of transforming growth factor-β signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem. 2003;278:18714–19.
   PubMed Web of Science ®Google Scholar
• Kang JS, Saunier EF, Akhurst RJ, Derynck R. The type I TGF-β receptor is covalently modified and regulated by sumoylation. Nat Cell Biol. 2008;10:654–64.
   PubMed Web of Science ®Google Scholar
• Gronroos E, Hellman U, Heldin CH, Ericsson J. Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell. 2002;10:483–93.
   PubMed Web of Science ®Google Scholar
• Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isshiki K, SIRT1 inhibits transforming growth factor β-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem. 2007;282:151–8.
   PubMed Web of Science ®Google Scholar
• Simonsson M, Heldin CH, Ericsson J, Gronroos E. The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem. 2005;280:21797–803.
   PubMed Web of Science ®Google Scholar
• Hellwinkel OJ, Asong LE, Rogmann JP, Sultmann H, Wagner C, Schlomm T, Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma. Prostate Cancer Prostatic Dis. 2011;14:38–45.
   PubMed Web of Science ®Google Scholar
• Fukasawa H, Yamamoto T, Fujigaki Y, Misaki T, Ohashi N, Takayama T, Reduction of transforming growth factor-β type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. Int J Cancer. 2010;127:1517–25.
   PubMed Web of Science ®Google Scholar
• Kwei KA, Shain AH, Bair R, Montgomery K, Karikari CA, van de Rijn M, SMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One. 2011;6:e23924.
   Google Scholar
• Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol. 2007;27:6068–83.
   PubMed Web of Science ®Google Scholar
• Nagano Y, Koinuma D, Miyazawa K, Miyazono K. Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells. J Biochem. 2010;147:545–54.
   PubMed Web of Science ®Google Scholar
• Sacco JJ, Coulson JM, Clague MJ, Urbe S. Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life. 2010;62:140–57.
   PubMed Web of Science ®Google Scholar
• Cohen P, Tcherpakov M. Will the ubiquitin system furnish as many drug targets as protein kinases? Cell. 2010;143:686–93.
   PubMed Web of Science ®Google Scholar
• Guedat P, Colland F. Patented small molecule inhibitors in the ubiquitin proteasome system. BMC Biochem. 2007;8(Suppl 1):S14.
   PubMedGoogle Scholar
• Heldin CH, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465–71.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Kurisaki A, Yamakawa N, Minakuchi K, Sugino H. FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor. J Mol Endocrinol. 2006;36:569–79.
   PubMed Web of Science ®Google Scholar
• Sangadala S, Boden SD, Viggeswarapu M, Liu Y, Titus L. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. J Biol Chem. 2006;281:17212–19.
   PubMed Web of Science ®Google Scholar
• Lo RS, Massague J. Ubiquitin-dependent degradation of TGF-β-activated smad2. Nat Cell Biol. 1999;1:472–8.
   PubMed Web of Science ®Google Scholar
• Seo SR, Lallemand F, Ferrand N, Pessah M, L'Hoste S, Camonis J, The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 2004;23:3780–92.
   PubMed Web of Science ®Google Scholar
• Liang M, Liang YY, Wrighton K, Ungermannova D, Wang XP, Brunicardi FC, Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol. 2004;24:7524–37.
   PubMed Web of Science ®Google Scholar
• Wan Y, Liu X, Kirschner MW. The anaphase-promoting complex mediates TGF-β signaling by targeting SnoN for destruction. Mol Cell. 2001;8:1027–39.
   PubMed Web of Science ®Google Scholar
• Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science. 2003;302:1775–9.
   PubMed Web of Science ®Google Scholar